ICUI - ICU Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
3.22B
Enterprise Value 3
2.94B
Trailing P/E
72.17
Forward P/E 1
20.77
PEG Ratio (5 yr expected) 1
1.25
Price/Sales (ttm)
2.46
Price/Book (mrq)
2.44
Enterprise Value/Revenue 3
2.24
Enterprise Value/EBITDA 6
12.65

Trading Information

Stock Price History

Beta (3Y Monthly) 1.09
52-Week Change 3-41.11%
S&P500 52-Week Change 38.78%
52 Week High 3284.69
52 Week Low 3148.89
50-Day Moving Average 3157.49
200-Day Moving Average 3208.70

Share Statistics

Avg Vol (3 month) 3252.79k
Avg Vol (10 day) 3236.37k
Shares Outstanding 520.67M
Float 19.19M
% Held by Insiders 17.13%
% Held by Institutions 193.55%
Shares Short (Sep 30, 2019) 4763.23k
Short Ratio (Sep 30, 2019) 42.86
Short % of Float (Sep 30, 2019) 45.57%
Short % of Shares Outstanding (Sep 30, 2019) 43.69%
Shares Short (prior month Aug 30, 2019) 4740.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/3
Last Split Date 3Mar 18, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 3.56%
Operating Margin (ttm)11.89%

Management Effectiveness

Return on Assets (ttm)6.19%
Return on Equity (ttm)3.63%

Income Statement

Revenue (ttm)1.31B
Revenue Per Share (ttm)63.85
Quarterly Revenue Growth (yoy)-13.40%
Gross Profit (ttm)570.03M
EBITDA 232.56M
Net Income Avi to Common (ttm)46.7M
Diluted EPS (ttm)2.16
Quarterly Earnings Growth (yoy)-26.50%

Balance Sheet

Total Cash (mrq)314.88M
Total Cash Per Share (mrq)15.24
Total Debt (mrq)37.48M
Total Debt/Equity (mrq)2.84
Current Ratio (mrq)3.58
Book Value Per Share (mrq)63.78

Cash Flow Statement

Operating Cash Flow (ttm)103.52M
Levered Free Cash Flow (ttm)108.18M